Allergy Research Group is pleased to announce our upcoming webinar: Next Generation Nutraceutical Delivery Systems: Liposomes and Nanoemulsions
Join us on August 19th at 3 PM PT, when Dr. Christopher Shade, PhD, CEO and founder of Quicksilver Scientific, explains what makes a quality liposome and nanoemulsion and why this next generation technology is changing the way we look at nutraceutical supplementation delivery. Learn how nanoparticle formulations offer greater bioavailability, working on a cellular level thus supporting more consistent, therapeutic outcomes.
A special discount offer on Allergy Research Group products will be revealed to live attendees before the webinar ends.
We hope you can join us live on August 19th at 3 PM PT. If not, donâ€™t worry, signing up will still grant you access to the webinar recording.
Register for the free webinar today at https://us02web.zoom.us/webinar/register/WN_-MmNSlMSTdGGifhLk3dnjg
Christopher Shade, PhD, founder and CEO of Quicksilver Scientific, continues to be the driving force of development and innovation. Dr. Shade is a recognized expert on mercury and liposomal delivery systems. He has lectured and trained doctors in the U.S. and internationally on the subject of mercury, heavy metals, and the human detoxification system. Dr. Shade’s current focus is on the development of cutting-edge, lipid-based delivery systems for nutraceuticals, such as liposomes and micro-emulsion systems, to address the growing need of high quality, affordable detoxification solutions.